Questionnaires and timing of assessments
| Timing* . | Marrow donors . | PBSC donors . | P value1-153 . | ||
|---|---|---|---|---|---|
| Questionnaire† . | No.‡ . | Questionnaire† . | No.‡ . | ||
| Baseline | A, B | 38 | A, B | 30 | — |
| Day −3 | — | — | A | — | |
| Day −1 | — | — | A | — | |
| Day +1 | A, B | 34 | A, B | 25 | .49 |
| Day +7 | A | 30 | A | 23 | 1.00 |
| Day +14 | A | 29 | A | 21 | .59 |
| Day +21 | A | 26 | A | 19 | .80 |
| Day +281-155 | A | 24 | A | 18 | .81 |
| 6 months | A, B | A, B | |||
| Timing* . | Marrow donors . | PBSC donors . | P value1-153 . | ||
|---|---|---|---|---|---|
| Questionnaire† . | No.‡ . | Questionnaire† . | No.‡ . | ||
| Baseline | A, B | 38 | A, B | 30 | — |
| Day −3 | — | — | A | — | |
| Day −1 | — | — | A | — | |
| Day +1 | A, B | 34 | A, B | 25 | .49 |
| Day +7 | A | 30 | A | 23 | 1.00 |
| Day +14 | A | 29 | A | 21 | .59 |
| Day +21 | A | 26 | A | 19 | .80 |
| Day +281-155 | A | 24 | A | 18 | .81 |
| 6 months | A, B | A, B | |||
PBSC indicates peripheral blood stem cell.
Day −3 is the third day of filgrastim administration; day −1 is the fifth day of filgrastim administration and the first day of apheresis. Day +1 is the day after marrow harvesting and the day after the completion of the last apheresis procedure if more than one was performed.
Questionnaire A indicates questionnaires on physical status, emotional status, symptom checklist, brief pain inventory, and McGill Pain Questionnaire; questionnaire B indicates profile of mood states and Better Person Inventory.
Number of donors who returned questionnaires at the indicated time point.
Exact P value (permutation test) for the null hypothesis that the proportions lost to follow-up are equal in the 2 treatment populations at each assessment point.
Donors were requested to complete questionnaire A on a weekly basis until return to baseline status as determined by the donor.